Ahsan H .2015 .Diabetic retinopathy -Biomolecules and multiple pathophysiology. Diabetes Metab. Syndr, 9(1) : 51-54.
Chan DT,Dogra GK,Irish AB,Ooi EM,Barrett PH,Chan DC,Watts GF .2009 .Chronic kidney disease delays VLDL-apoB-100 particle catabolism: Potential role of apolipoprotein C-III. J. Lipid Res., 50(12) : 2524-2531.
Chasapis CT,Ntoupa PSA,Spiliopoulou CA,Stefanidou ME .2020 .Recent aspects of the effects of zinc on human health. Arch. Toxicl., 94(5) : 1443-1460.
Deguchi Y,Maeno T,Saishin Y,Hori Y,Shiba T,Takahashi M .2011 .Relevance of the serum apolipoprotein ratio to diabetic retinopathy. Jpn. J. Ophthalmol., 55(2) : 128-131.
Duh EJ,Sun JK,Stitt AW .2017 .Diabetic retinopathy: current understanding, mechanisms and treatment strategies. JCI Insight, 2(14) : e93751.
Frondelius K,Borg M,Ericson U,Borne Y,Melander O,Sonestedt E .2017 .Lifestyle and dietary determinants of serum apolipoprotein a1 and apolipoprotein b concentrations: Cross-sectional analyses within a Swedish cohort of 24,984 individuals. , 9(3) : 211.
Page S Hewapathirana N .2012 .Diabetic microvascular complications - screening, diagnosis and prevention. Clin. Focus Pri. Care, 6(3) : 177-191.
Hu A,Luo Y,Li T,Guo X,Ding X,Zhu X,Wang X,Tang S X .2012 .Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes. Graefes Arch. Clin. Exp, 250(7) : 957-962.
Jarosz M,Olbert M,Wuszogrodzka G,Mlyniec K,Librowski T .2017 .Antioxidant and antiinflammatory effects of zinc. Zinc-dependent NF-κB signaling. Inflammopharmacology, 25(1) : 11-24.
Kanani FH,Alam JM .2010 .Apolipoprotein B in Type 2 diabetics a cross sectional study in a tertiary care set-up. JPMA, 60(8) : 653.
Khalid N,Ahmed DA,Bhatti M,Randhawa M,Ahmad A,Rafaqat R .2014 .A question mark on zinc deficiency in 185 million people in Pakistan-possible way out. Crit. Rev. Food Sci. Nutr, 54(9) : 1222-40.
Kilhovd BK,Berg TJ,Birkeland KI,Thorsby P,Hanssen KF .1999 .Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care, 22(9) : 1543-1548.
Pak. J. Pharm. Sci. ,Koska J,Saremi A,Howell S,Bahn G,De Courten B,Ginsberg H,Beisswenger PJ,Reaven PD .2018 .Advanced glycation end products, Oxidation products, and incident cardiovascular events in patients with type 2 diabetes. Diabetes Care, 41(3) : 570-576.
Kumari S,Pradhan T,Panda T,Bangladesh J. M. Sci T .2014 .Trace Minerals and Oxidative Stress in Diabetic Retinopathy. , 13(2) : 175-179.
Luo YY,Zhao J,Han XY,Zhou XH,Wu J,Ji LN .2015 .Relationship between serum zinc level and microvascular complications in patients with type 2 diabetes. , 128(24) : 3276.
Movahedi Rad M,Rabizadeh S,Salehi S,Mirmiranpour H,Esteghamati A,Jafari R,Nakhjavani M .2017 .Advanced end glycation products, Advanced oxidation protein products and ferritin reducing ability of plasma as markers of diabetic retinopathy. Austin J. Endo. Diabetes, 4(1) : 1057-1062.
Namitha D,Nusrath A,Rajeswari A,Rani NA,Shilpashree YD .2017 .Apolipoprotein A-1 and apolipoprotein B: Better indicators of dyslipidemia in diabetic retinopathy patients? Indian J. , 21(2) : 142-146.
Ono Y,Aoki S,Ohnishi K,Yasuda T,Kawano K,Tsukada Y .1998 .Increased serum levels of advanced glycation end-products and diabetic complications. Diabetes Res. Clin. Pract, 41(2) : 131-137.
Prakash G,Agrawal R,Satsangi SK,Prakash S SK .2016 .Comparison of Serum Apolipoproteins and Traditional Lipids in Eyes with Diabetic Retinopathy in Indian Population: A Case Series. Middle East Afr. , 23(2) : 212-214.
Prasad AS .2014 .Zinc is an antioxidant and antiinflammatory agent: Its role in human health. Frontiers in Nutrition, 1(14) : 1-10.
Praveena S,Sujatha P,Ganesh B .2013 .Study of micro elements in Diabetic Retinopathy. J. Med, 2(6) : 531-537.
Rathnakumar Krishnamoorthy RK,Ramesh Venkatachalam R Poovitha and Geetha Rajagopalan RK .2017 .Apolipoproteins an early and better diagnostic marker for diabetic retinopathy. J. Clin. Diagnostic Res., 11(10) : NC01-NC05.
Sasongko MB,Wong TY,Nguyen TT,Kawasaki R,Jenkins A,Shaw J,Wang JJ .2011 .Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids. Diabetes Care, 34(2) : 474-479.
Sharma Y,Saxena S,Mishra A,Saxena A,Natu SM .2012 .Advanced glycation end products and diabetic retinopathy. J. Ocul. Bio, 5(3) : 63-69.
Wagner Z,Wittmann I,Mazak I,Schinzel R,Heidland A,Kienysch-Engel R,Nagy J .2001 .Nϵ- (carboxymethyl) lysine levels in patients with type 2 diabetes: Role of renal function. AJKDD, 38(4) : 785-791.
Wilkinson CP,Ferris FL,Klein RE,Lee PP,Agardh CD,Davis M,Dills D,Kampik A,Pararajasegaram R,Verdaguer JT .2003 .Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology, 110(9) : 1677-1682.
Wu M,Chen Y,Wilson K,Chirindel A,Ihnat MA,Yu Y,Boulton ME,Szweda LI,Ma JX,Lyons TJ .2008 .Intraretinal leakage and oxidation of LDL in diabetic retinopathy. IOVS, 49(6) : 2679-85.
Yu JY,Lyons TJ .2013 .Modified lipoproteins in diabetic retinopathy: A local action in the retina. J. Clin. Exp, 4(6) : 314.